Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use
    5.
    发明申请
    Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use 失效
    早期前列腺癌抗原(epca),编码它们的多核苷酸序列及其用途

    公开(公告)号:US20060148011A1

    公开(公告)日:2006-07-06

    申请号:US10514735

    申请日:2004-03-01

    申请人: Robert Getzenberg

    发明人: Robert Getzenberg

    IPC分类号: G01N33/574

    摘要: A novel prostate cancer marker is described that is found in cancerous and normal prostate cells of individuals that have prostate cancer but is not found in the prostate of individuals without prostate cancer. The marker also is present in normal tissue adjacent to tumor tissue in individuals having prostate cancer. The marker, however, is absent in the prostate of individuals without prostate cancer. Methods employing the novel prostate cancer marker of the invention to predict the occurrence of the prostate disease, monitor the progression of prostate cancer and effect the treatment of prostate cancer, also are described.

    摘要翻译: 描述了一种新型前列腺癌标记,其在具有前列腺癌但在前列腺癌的个体的前列腺中未发现的个体的癌性和正常前列腺细胞中发现。 该标记物也存在于患有前列腺癌的个体中与肿瘤组织相邻的正常组织中。 然而,在没有前列腺癌的个体的前列腺中不存在该标记。 还描述了使用本发明的新型前列腺癌标志物来预测前列腺疾病的发生,监测前列腺癌的进展和影响前列腺癌的治疗的方法。